イダルビシンHClのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Idarubicin HCl Market Insights and Forecast to 2027

• レポートコード：QY2112C00182
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料はイダルビシンHClの世界市場の現状について調査・分析し、2027年までの市場を予測しました。イダルビシンHClの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99.6％、その他）、用途別市場規模（腫瘍、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・イダルビシンHClの世界市場概要
・メーカー別の競争状況、市場シェア
・イダルビシンHClの種類別市場規模：純度99.6％、その他
・イダルビシンHClの用途別市場規模：腫瘍、その他
・北米のイダルビシンHCl市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパのイダルビシンHCl市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアのイダルビシンHCl市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米のイダルビシンHCl市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカのイダルビシンHCl市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：Synbias Pharma、Teva API、Zhejiang Hisun Pharmaceutical、DZD(Heze)Pharmaceutical
・イダルビシンHClのバリューチェーン・販売チャネル分析
・イダルビシンHClの世界市場動向

Market Analysis and Insights: Global Idarubicin HCl Market
The global Idarubicin HCl market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Idarubicin HCl Scope and Segment
Idarubicin HCl market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Idarubicin HCl market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
99.6% Purity
Other

Segment by Application
Oncology
Other

By Company
Synbias Pharma
Teva API
Zhejiang Hisun Pharmaceutical
DZD(Heze)Pharmaceutical

Production by Region
North America
Europe
China
India

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Idarubicin HCl Product Introduction
1.2 Market by Type
1.2.1 Global Idarubicin HCl Market Size Growth Rate by Type
1.2.2 99.6% Purity
1.2.3 Other
1.3 Market by Application
1.3.1 Global Idarubicin HCl Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Idarubicin HCl Production
2.1 Global Idarubicin HCl Production Capacity (2016-2027)
2.2 Global Idarubicin HCl Production by Region: 2016 VS 2021 VS 2027
2.3 Global Idarubicin HCl Production by Region
2.3.1 Global Idarubicin HCl Historic Production by Region (2016-2021)
2.3.2 Global Idarubicin HCl Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 India

3 Global Idarubicin HCl Sales in Volume & Value Estimates and Forecasts
3.1 Global Idarubicin HCl Sales Estimates and Forecasts 2016-2027
3.2 Global Idarubicin HCl Revenue Estimates and Forecasts 2016-2027
3.3 Global Idarubicin HCl Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Idarubicin HCl Regions by Sales
3.4.1 Global Top Idarubicin HCl Regions by Sales (2016-2021)
3.4.2 Global Top Idarubicin HCl Regions by Sales (2022-2027)
3.5 Global Top Idarubicin HCl Regions by Revenue
3.5.1 Global Top Idarubicin HCl Regions by Revenue (2016-2021)
3.5.2 Global Top Idarubicin HCl Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Idarubicin HCl Production Capacity by Manufacturers
4.2 Global Idarubicin HCl Sales by Manufacturers
4.2.1 Global Top Idarubicin HCl Manufacturers by Sales (2016-2021)
4.2.2 Global Top Idarubicin HCl Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Idarubicin HCl Sales in 2020
4.3 Global Idarubicin HCl Revenue by Manufacturers
4.3.1 Global Top Idarubicin HCl Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Idarubicin HCl Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Idarubicin HCl Revenue in 2020
4.4 Global Idarubicin HCl Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Idarubicin HCl Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Idarubicin HCl Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Idarubicin HCl Sales by Type
5.1.1 Global Idarubicin HCl Historical Sales by Type (2016-2021)
5.1.2 Global Idarubicin HCl Forecasted Sales by Type (2022-2027)
5.1.3 Global Idarubicin HCl Sales Market Share by Type (2016-2027)
5.2 Global Idarubicin HCl Revenue by Type
5.2.1 Global Idarubicin HCl Historical Revenue by Type (2016-2021)
5.2.2 Global Idarubicin HCl Forecasted Revenue by Type (2022-2027)
5.2.3 Global Idarubicin HCl Revenue Market Share by Type (2016-2027)
5.3 Global Idarubicin HCl Price by Type
5.3.1 Global Idarubicin HCl Price by Type (2016-2021)
5.3.2 Global Idarubicin HCl Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Idarubicin HCl Sales by Application
6.1.1 Global Idarubicin HCl Historical Sales by Application (2016-2021)
6.1.2 Global Idarubicin HCl Forecasted Sales by Application (2022-2027)
6.1.3 Global Idarubicin HCl Sales Market Share by Application (2016-2027)
6.2 Global Idarubicin HCl Revenue by Application
6.2.1 Global Idarubicin HCl Historical Revenue by Application (2016-2021)
6.2.2 Global Idarubicin HCl Forecasted Revenue by Application (2022-2027)
6.2.3 Global Idarubicin HCl Revenue Market Share by Application (2016-2027)
6.3 Global Idarubicin HCl Price by Application
6.3.1 Global Idarubicin HCl Price by Application (2016-2021)
6.3.2 Global Idarubicin HCl Price Forecast by Application (2022-2027)

7 North America
7.1 North America Idarubicin HCl Market Size by Type
7.1.1 North America Idarubicin HCl Sales by Type (2016-2027)
7.1.2 North America Idarubicin HCl Revenue by Type (2016-2027)
7.2 North America Idarubicin HCl Market Size by Application
7.2.1 North America Idarubicin HCl Sales by Application (2016-2027)
7.2.2 North America Idarubicin HCl Revenue by Application (2016-2027)
7.3 North America Idarubicin HCl Sales by Country
7.3.1 North America Idarubicin HCl Sales by Country (2016-2027)
7.3.2 North America Idarubicin HCl Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Idarubicin HCl Market Size by Type
8.1.1 Europe Idarubicin HCl Sales by Type (2016-2027)
8.1.2 Europe Idarubicin HCl Revenue by Type (2016-2027)
8.2 Europe Idarubicin HCl Market Size by Application
8.2.1 Europe Idarubicin HCl Sales by Application (2016-2027)
8.2.2 Europe Idarubicin HCl Revenue by Application (2016-2027)
8.3 Europe Idarubicin HCl Sales by Country
8.3.1 Europe Idarubicin HCl Sales by Country (2016-2027)
8.3.2 Europe Idarubicin HCl Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Idarubicin HCl Market Size by Type
9.1.1 Asia Pacific Idarubicin HCl Sales by Type (2016-2027)
9.1.2 Asia Pacific Idarubicin HCl Revenue by Type (2016-2027)
9.2 Asia Pacific Idarubicin HCl Market Size by Application
9.2.1 Asia Pacific Idarubicin HCl Sales by Application (2016-2027)
9.2.2 Asia Pacific Idarubicin HCl Revenue by Application (2016-2027)
9.3 Asia Pacific Idarubicin HCl Sales by Region
9.3.1 Asia Pacific Idarubicin HCl Sales by Region (2016-2027)
9.3.2 Asia Pacific Idarubicin HCl Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Idarubicin HCl Market Size by Type
10.1.1 Latin America Idarubicin HCl Sales by Type (2016-2027)
10.1.2 Latin America Idarubicin HCl Revenue by Type (2016-2027)
10.2 Latin America Idarubicin HCl Market Size by Application
10.2.1 Latin America Idarubicin HCl Sales by Application (2016-2027)
10.2.2 Latin America Idarubicin HCl Revenue by Application (2016-2027)
10.3 Latin America Idarubicin HCl Sales by Country
10.3.1 Latin America Idarubicin HCl Sales by Country (2016-2027)
10.3.2 Latin America Idarubicin HCl Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Idarubicin HCl Market Size by Type
11.1.1 Middle East and Africa Idarubicin HCl Sales by Type (2016-2027)
11.1.2 Middle East and Africa Idarubicin HCl Revenue by Type (2016-2027)
11.2 Middle East and Africa Idarubicin HCl Market Size by Application
11.2.1 Middle East and Africa Idarubicin HCl Sales by Application (2016-2027)
11.2.2 Middle East and Africa Idarubicin HCl Revenue by Application (2016-2027)
11.3 Middle East and Africa Idarubicin HCl Sales by Country
11.3.1 Middle East and Africa Idarubicin HCl Sales by Country (2016-2027)
11.3.2 Middle East and Africa Idarubicin HCl Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Synbias Pharma
12.1.1 Synbias Pharma Corporation Information
12.1.2 Synbias Pharma Overview
12.1.3 Synbias Pharma Idarubicin HCl Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Synbias Pharma Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Synbias Pharma Recent Developments
12.2 Teva API
12.2.1 Teva API Corporation Information
12.2.2 Teva API Overview
12.2.3 Teva API Idarubicin HCl Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Teva API Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Teva API Recent Developments
12.3 Zhejiang Hisun Pharmaceutical
12.3.1 Zhejiang Hisun Pharmaceutical Corporation Information
12.3.2 Zhejiang Hisun Pharmaceutical Overview
12.3.3 Zhejiang Hisun Pharmaceutical Idarubicin HCl Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Zhejiang Hisun Pharmaceutical Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Zhejiang Hisun Pharmaceutical Recent Developments
12.4 DZD(Heze)Pharmaceutical
12.4.1 DZD(Heze)Pharmaceutical Corporation Information
12.4.2 DZD(Heze)Pharmaceutical Overview
12.4.3 DZD(Heze)Pharmaceutical Idarubicin HCl Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 DZD(Heze)Pharmaceutical Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 DZD(Heze)Pharmaceutical Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Idarubicin HCl Industry Chain Analysis
13.2 Idarubicin HCl Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Idarubicin HCl Production Mode & Process
13.4 Idarubicin HCl Sales and Marketing
13.4.1 Idarubicin HCl Sales Channels
13.4.2 Idarubicin HCl Distributors
13.5 Idarubicin HCl Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Idarubicin HCl Industry Trends
14.2 Idarubicin HCl Market Drivers
14.3 Idarubicin HCl Market Challenges
14.4 Idarubicin HCl Market Restraints

15 Key Finding in The Global Idarubicin HCl Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Idarubicin HCl Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 99.6% Purity
Table 3. Major Manufacturers of Other
Table 4. Global Idarubicin HCl Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Idarubicin HCl Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Idarubicin HCl Production by Region (2016-2021) & (Ton)
Table 7. Global Idarubicin HCl Production Market Share by Region (2016-2021)
Table 8. Global Idarubicin HCl Production by Region (2022-2027) & (Ton)
Table 9. Global Idarubicin HCl Production Market Share by Region (2022-2027)
Table 10. Global Idarubicin HCl Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Idarubicin HCl Sales by Region (2016-2021) & (Ton)
Table 12. Global Idarubicin HCl Sales Market Share by Region (2016-2021)
Table 13. Global Idarubicin HCl Sales by Region (2022-2027) & (Ton)
Table 14. Global Idarubicin HCl Sales Market Share by Region (2022-2027)
Table 15. Global Idarubicin HCl Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Idarubicin HCl Revenue Market Share by Region (2016-2021)
Table 17. Global Idarubicin HCl Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Idarubicin HCl Revenue Market Share by Region (2022-2027)
Table 19. Global Idarubicin HCl Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Idarubicin HCl Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Idarubicin HCl Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Idarubicin HCl Production Market Share by Manufacturers (2016-2021)
Table 23. Global Idarubicin HCl Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Idarubicin HCl Sales Share by Manufacturers (2016-2021)
Table 25. Global Idarubicin HCl Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Idarubicin HCl Revenue Share by Manufacturers (2016-2021)
Table 27. Idarubicin HCl Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Idarubicin HCl Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Idarubicin HCl by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idarubicin HCl as of 2020)
Table 30. Idarubicin HCl Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Idarubicin HCl Product Offered
Table 32. Date of Manufacturers Enter into Idarubicin HCl Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 35. Global Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 36. Global Idarubicin HCl Sales Share by Type (2016-2021)
Table 37. Global Idarubicin HCl Sales Share by Type (2022-2027)
Table 38. Global Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Idarubicin HCl Revenue Share by Type (2016-2021)
Table 41. Global Idarubicin HCl Revenue Share by Type (2022-2027)
Table 42. Idarubicin HCl Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Idarubicin HCl Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 45. Global Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 46. Global Idarubicin HCl Sales Share by Application (2016-2021)
Table 47. Global Idarubicin HCl Sales Share by Application (2022-2027)
Table 48. Global Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Idarubicin HCl Revenue Share by Application (2016-2021)
Table 51. Global Idarubicin HCl Revenue Share by Application (2022-2027)
Table 52. Idarubicin HCl Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Idarubicin HCl Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 55. North America Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 56. North America Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 59. North America Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 60. North America Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Idarubicin HCl Sales by Country (2016-2021) & (Ton)
Table 63. North America Idarubicin HCl Sales by Country (2022-2027) & (Ton)
Table 64. North America Idarubicin HCl Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Idarubicin HCl Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 67. Europe Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 68. Europe Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 71. Europe Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 72. Europe Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Idarubicin HCl Sales by Country (2016-2021) & (Ton)
Table 75. Europe Idarubicin HCl Sales by Country (2022-2027) & (Ton)
Table 76. Europe Idarubicin HCl Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Idarubicin HCl Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Idarubicin HCl Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Idarubicin HCl Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Idarubicin HCl Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Idarubicin HCl Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Idarubicin HCl Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Idarubicin HCl Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Idarubicin HCl Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Idarubicin HCl Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Idarubicin HCl Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Idarubicin HCl Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Idarubicin HCl Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Idarubicin HCl Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Idarubicin HCl Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Idarubicin HCl Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Idarubicin HCl Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Idarubicin HCl Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Idarubicin HCl Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Idarubicin HCl Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Idarubicin HCl Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Idarubicin HCl Revenue by Country (2022-2027) & (US$ Million)
Table 114. Synbias Pharma Corporation Information
Table 115. Synbias Pharma Description and Major Businesses
Table 116. Synbias Pharma Idarubicin HCl Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Synbias Pharma Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Synbias Pharma Recent Development
Table 119. Teva API Corporation Information
Table 120. Teva API Description and Major Businesses
Table 121. Teva API Idarubicin HCl Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Teva API Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Teva API Recent Development
Table 124. Zhejiang Hisun Pharmaceutical Corporation Information
Table 125. Zhejiang Hisun Pharmaceutical Description and Major Businesses
Table 126. Zhejiang Hisun Pharmaceutical Idarubicin HCl Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Zhejiang Hisun Pharmaceutical Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Zhejiang Hisun Pharmaceutical Recent Development
Table 129. DZD(Heze)Pharmaceutical Corporation Information
Table 130. DZD(Heze)Pharmaceutical Description and Major Businesses
Table 131. DZD(Heze)Pharmaceutical Idarubicin HCl Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. DZD(Heze)Pharmaceutical Idarubicin HCl Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. DZD(Heze)Pharmaceutical Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Idarubicin HCl Distributors List
Table 137. Idarubicin HCl Customers List
Table 138. Idarubicin HCl Market Trends
Table 139. Idarubicin HCl Market Drivers
Table 140. Idarubicin HCl Market Challenges
Table 141. Idarubicin HCl Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Idarubicin HCl Product Picture
Figure 2. Global Idarubicin HCl Market Share by Type in 2020 & 2027
Figure 3. 99.6% Purity Product Picture
Figure 4. Other Product Picture
Figure 5. Global Idarubicin HCl Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Other
Figure 8. Idarubicin HCl Report Years Considered
Figure 9. Global Idarubicin HCl Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Idarubicin HCl Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Idarubicin HCl Production Market Share by Region (2016-2021)
Figure 12. Global Idarubicin HCl Production Market Share by Region (2022-2027)
Figure 13. Idarubicin HCl Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Idarubicin HCl Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Idarubicin HCl Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Idarubicin HCl Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Global Idarubicin HCl Sales 2016-2027 (Ton)
Figure 18. Global Idarubicin HCl Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Idarubicin HCl Revenue 2016-2027 (US$ Million)
Figure 20. Global Idarubicin HCl Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Idarubicin HCl Sales Market Share by Region (2016-2021)
Figure 22. Global Idarubicin HCl Sales Market Share by Region (2022-2027)
Figure 23. North America Idarubicin HCl Sales YoY (2016-2027) & (Ton)
Figure 24. North America Idarubicin HCl Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Idarubicin HCl Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Idarubicin HCl Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Idarubicin HCl Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Idarubicin HCl Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Idarubicin HCl Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Idarubicin HCl Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Idarubicin HCl Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Idarubicin HCl Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Idarubicin HCl Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Idarubicin HCl Revenue in 2020
Figure 35. Idarubicin HCl Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 37. Global Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 38. Global Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 39. Global Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 40. North America Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 41. North America Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 42. North America Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 43. North America Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 44. North America Idarubicin HCl Sales Share by Country (2016-2027)
Figure 45. North America Idarubicin HCl Revenue Share by Country (2016-2027)
Figure 46. United States Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 49. Europe Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 50. Europe Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 51. Europe Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 52. Europe Idarubicin HCl Sales Share by Country (2016-2027)
Figure 53. Europe Idarubicin HCl Revenue Share by Country (2016-2027)
Figure 54. Germany Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 55. France Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Idarubicin HCl Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Idarubicin HCl Revenue Share by Region (2016-2027)
Figure 65. China Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 68. India Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 75. Latin America Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 77. Latin America Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Idarubicin HCl Sales Share by Country (2016-2027)
Figure 79. Latin America Idarubicin HCl Revenue Share by Country (2016-2027)
Figure 80. Mexico Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Idarubicin HCl Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Idarubicin HCl Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Idarubicin HCl Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Idarubicin HCl Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Idarubicin HCl Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Idarubicin HCl Revenue Share by Country (2016-2027)
Figure 89. Turkey Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Idarubicin HCl Revenue (2016-2027) & (US$ Million)
Figure 92. Idarubicin HCl Value Chain
Figure 93. Idarubicin HCl Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

イダルビシン塩酸塩のグローバル市場インサイト・予測（～2027年）

Global Idarubicin Hydrochloride Market Insights and Forecast to 2027
QY2112C00183 2021年12月 85Pages
本調査資料はイダルビシン塩酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。イダルビシン塩酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99.6％、その他）、用途別市場規模（腫瘍、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア...

硬質PVCパイプのグローバル市場インサイト・予測（～2027年）

Global Rigid PVC Pipe Market Insights and Forecast to 2027
QY2112C01049 2021年12月 128Pages
本調査資料は硬質PVCパイプの世界市場の現状について調査・分析し、2027年までの市場を予測しました。硬質PVCパイプの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（直径25mm〜100mm、直径100mm〜200mm、直径200mm〜300mm、その他）、用途別市場規模（工業用パ...

PTFEテフロングランドパッキンのグローバル市場インサイト・予測（～2027年）

Global PTFE Teflon Gland Packing Market Insights and Forecast to 2027
QY2112C00984 2021年12月 113Pages
本調査資料はPTFEテフロングランドパッキンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。PTFEテフロングランドパッキンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（オイルあり、オイルなし）、用途別市場規模（化学、製薬、食品・砂糖、紙・パルプ）、主要...

自動車シート用PU高弾性離型剤のグローバル市場インサイト・予測（～2027年）

Global PU High Resilience Release Agent for Car Seats Market Insights and Forecast to 2027
QY2112C00990 2021年12月 113Pages
本調査資料は自動車シート用PU高弾性離型剤の世界市場の現状について調査・分析し、2027年までの市場を予測しました。自動車シート用PU高弾性離型剤の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（水性、油性）、用途別市場規模（乗用車、商用車）、主要地域別市場規模（北米・アメリカ、ヨー...

ニセルゴリンのグローバル市場インサイト・予測（～2027年）

Global Nicergoline Market Insights and Forecast to 2027
QY2112C00599 2021年12月 125Pages
本調査資料はニセルゴリンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ニセルゴリンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（98％以下、98％〜99％、99％以上）、用途別市場規模（老人性認知症治療、心血管疾患治療、その他）、主要地域別市場規模（北...

M-クロロベンズアルデヒドのグローバル市場インサイト・予測（～2027年）

Global M-chlorobenzaldehyde Market Insights and Forecast to 2027
QY2112C00412 2021年12月 100Pages
本調査資料はM-クロロベンズアルデヒドの世界市場の現状について調査・分析し、2027年までの市場を予測しました。M-クロロベンズアルデヒドの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度98％、純度99％）、用途別市場規模（農薬中間体、医薬中間体、染料、その他）、主要地域別市場...

シリカロープ＆スリーブのグローバル市場インサイト・予測（～2027年）

Global Silica Ropes and Sleeves Market Insights and Forecast to 2027
QY2112C01149 2021年12月 113Pages
本調査資料はシリカロープ＆スリーブの世界市場の現状について調査・分析し、2027年までの市場を予測しました。シリカロープ＆スリーブの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（シリカロープ、シリカスリーブ）、用途別市場規模（自動車、航空宇宙、建設、電力、石油・ガス、金属、その他）...

AlベースCCL用球状アルミナのグローバル市場インサイト・予測（～2027年）

Global Spherical Alumina for Al Base CCL Market Insights and Forecast to 2027
QY2112C01239 2021年12月 95Pages
本調査資料はAlベースCCL用球状アルミナの世界市場の現状について調査・分析し、2027年までの市場を予測しました。AlベースCCL用球状アルミナの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（1〜5μm、5〜20μm、その他）、用途別市場規模（通信、家電、自動車、その他）、主要地...

硝酸スカンジウムのグローバル市場インサイト・予測（～2027年）

Global Scandium Nitrate Market Insights and Forecast to 2027
QY2112C01101 2021年12月 104Pages
本調査資料は硝酸スカンジウムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。硝酸スカンジウムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（化学、実験室、工業、その他）、主...

テルル化モリブデンスパッタリングターゲットのグローバル市場インサイト・予測（～2027年）

Global Molybdenum Telluride Sputtering Target Market Insights and Forecast to 2027
QY2112C00525 2021年12月 109Pages
本調査資料はテルル化モリブデンスパッタリングターゲットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。テルル化モリブデンスパッタリングターゲットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.5％、純度99.9％、純度99.95％、純...

イダルビシン塩酸塩のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Idarubicin Hydrochloride Market The global Idarubicin Hydrochloride market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Idarubicin Hydrochloride Scope and Segm…
腫瘍・抗がん剤のグローバル市場インサイト・予測（～2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors…
選択的エストロゲン受容体分解剤のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Selective Estrogen Receptor Degrader Market The global Selective Estrogen Receptor Degrader market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Selective Estrogen Rece…
太陽光エネルギーセル用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…
半導体用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…